Aclarion CEO to Present at 2024 Maxim Healthcare Virtual Summit

Aclarion, Inc. (Nasdaq: ACON, ACONW), a healthcare technology company focused on identifying the location of chronic low back pain, has announced its participation in the upcoming 2024 Maxim Healthcare Virtual Summit. The company's CEO, Brent Ness, is scheduled to present on Tuesday, October 15th, 2024, at 2:00 p.m. ET.

The Maxim Healthcare Virtual Summit, presented by Maxim Group LLC, will feature a series of presentations and interactive discussions with CEOs and key management from various biotechnology, diagnostic, medical device, and healthcare information technology companies. Senior analysts from Maxim will host these sessions, providing a platform for companies like Aclarion to showcase their innovations and strategies.

Aclarion's participation in this summit is significant as it underscores the company's position in the healthcare technology sector. The company's primary focus is on its Nociscan platform, which uses Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to help physicians distinguish between painful and nonpainful discs in the lumbar spine.

This technology represents a potentially groundbreaking approach to diagnosing and treating chronic low back pain, a condition that affects millions of people worldwide. By providing physicians with clearer insights into the source of a patient's pain, Aclarion's technology could lead to more targeted and effective treatment strategies, potentially improving patient outcomes and reducing healthcare costs.

The company's presence at the Maxim Healthcare Virtual Summit offers an opportunity for investors and industry professionals to gain deeper insights into Aclarion's technology and its potential impact on the healthcare industry. It also provides a platform for the company to attract potential partners and investors, which could accelerate the adoption and development of its innovative technology.

As the healthcare industry continues to embrace technological advancements, companies like Aclarion are at the forefront of transforming patient care. The company's participation in this summit highlights the growing interest in AI-driven diagnostic tools and their potential to revolutionize chronic pain management.